TD Ameritrade Investment Management’s Hologic HOLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-147
Closed -$12K 201
2023
Q2
$12K Sell
147
-63
-30% -$5.15K ﹤0.01% 333
2023
Q1
$17K Sell
210
-71
-25% -$5.72K ﹤0.01% 324
2022
Q4
$21K Buy
+281
New +$20K ﹤0.01% 322
2022
Q3
Sell
-567
Closed -$39K 614
2022
Q2
$39K Sell
567
-559
-50% -$41.5K ﹤0.01% 324
2022
Q1
$86K Buy
1,126
+115
+11% +$8.27K ﹤0.01% 310
2021
Q4
$77K Sell
1,011
-77
-7% -$5.66K ﹤0.01% 314
2021
Q3
$72K Buy
1,088
+471
+76% +$35.3K ﹤0.01% 286
2021
Q2
$41K Buy
+617
New +$41.2K ﹤0.01% 359
2020
Q4
Sell
-1,088
Closed -$72K 644
2020
Q3
$72K Sell
1,088
-2
-0.2% -$127 ﹤0.01% 286
2020
Q2
$62K Sell
1,090
-140
-11% -$6.87K ﹤0.01% 290
2020
Q1
$43K Buy
1,230
+265
+27% +$12.6K ﹤0.01% 307
2019
Q4
$50K Buy
965
+19
+2% +$946 ﹤0.01% 315
2019
Q3
$48K Sell
946
-18
-2% -$886 ﹤0.01% 293
2019
Q2
$46K Buy
964
+312
+48% +$14.4K ﹤0.01% 268
2019
Q1
$32K Buy
652
+445
+215% +$20.1K ﹤0.01% 280
2018
Q4
$9K Buy
207
+153
+283% +$6.28K ﹤0.01% 361
2018
Q3
$2K Buy
+54
New +$2.18K ﹤0.01% 490

Other funds holding HOLX

TD Ameritrade Investment Management's HOLX Position: Q3 2023 in Review

TD Ameritrade Investment Management sold out of Hologic (HOLX) in Q3 2023, closing a stake of 147 shares — an estimated $12K sold.

TD Ameritrade Investment Management first reported a position in HOLX in Q3 2018 and held it in 17 quarters. The position peaked at $86K in Q1 2022. 693 funds tracked by Wall St. Rank hold HOLX as of Q3 2023.

  • TD Ameritrade Investment Management reported no remaining Hologic position as of Q3 2023 after selling out during the quarter.
  • TD Ameritrade Investment Management sold 147 Hologic shares in Q3 2023, an estimated $12K.
  • TD Ameritrade Investment Management first reported a position in Hologic in Q3 2018 and held it in 17 quarters.
  • TD Ameritrade Investment Management's Hologic position peaked at $86K in Q1 2022.
  • 693 funds tracked by Wall St. Rank held Hologic as of Q3 2023.

Based on TD Ameritrade Investment Management's 13F filing for Q3 2023.